199 related articles for article (PubMed ID: 28275376)
1. Immunological Balance Is Associated with Clinical Outcome after Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes.
Malmegrim KC; de Azevedo JT; Arruda LC; Abreu JR; Couri CE; de Oliveira GL; Palma PV; Scortegagna GT; Stracieri AB; Moraes DA; Dias JB; Pieroni F; Cunha R; Guilherme L; Santos NM; Foss MC; Covas DT; Burt RK; Simões BP; Voltarelli JC; Roep BO; Oliveira MC
Front Immunol; 2017; 8():167. PubMed ID: 28275376
[TBL] [Abstract][Full Text] [Related]
2. Immunological correlates of favorable long-term clinical outcome in multiple sclerosis patients after autologous hematopoietic stem cell transplantation.
Arruda LCM; de Azevedo JTC; de Oliveira GLV; Scortegagna GT; Rodrigues ES; Palma PVB; Brum DG; Guerreiro CT; Marques VD; Barreira AA; Covas DT; Simões BP; Voltarelli JC; Oliveira MC; Malmegrim KCR
Clin Immunol; 2016 Aug; 169():47-57. PubMed ID: 27318116
[TBL] [Abstract][Full Text] [Related]
3. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
[TBL] [Abstract][Full Text] [Related]
4. Clinical benefits of autologous haematopoietic stem cell transplantation in type 1 diabetes patients.
Gu B; Miao H; Zhang J; Hu J; Zhou W; Gu W; Wang W; Ning G
Diabetes Metab; 2018 Sep; 44(4):341-345. PubMed ID: 29331269
[TBL] [Abstract][Full Text] [Related]
5. Immunological reconstitution after autologous stem cell transplantation in patients with refractory systemic autoimmune diseases.
Szodoray P; Varoczy L; Papp G; Barath S; Nakken B; Szegedi G; Zeher M
Scand J Rheumatol; 2012 Mar; 41(2):110-5. PubMed ID: 21936606
[TBL] [Abstract][Full Text] [Related]
6. Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus.
Ye L; Li L; Wan B; Yang M; Hong J; Gu W; Wang W; Ning G
Stem Cell Res Ther; 2017 Apr; 8(1):90. PubMed ID: 28420440
[TBL] [Abstract][Full Text] [Related]
7. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients.
Lima-Júnior JR; Arruda LCM; Gonçalves MS; Dias JBE; Moraes DA; Covas DT; Simões BP; Oliveira MC; Malmegrim KCR
Rheumatology (Oxford); 2021 Dec; 60(12):5538-5548. PubMed ID: 33724344
[TBL] [Abstract][Full Text] [Related]
8. Autologous hematopoietic stem cell transplantation modulates immunocompetent cells and improves β-cell function in Chinese patients with new onset of type 1 diabetes.
Li L; Shen S; Ouyang J; Hu Y; Hu L; Cui W; Zhang N; Zhuge YZ; Chen B; Xu J; Zhu D
J Clin Endocrinol Metab; 2012 May; 97(5):1729-36. PubMed ID: 22419704
[TBL] [Abstract][Full Text] [Related]
9. Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients.
Farge D; Arruda LC; Brigant F; Clave E; Douay C; Marjanovic Z; Deligny C; Maki G; Gluckman E; Toubert A; Moins-Teisserenc H
J Hematol Oncol; 2017 Jan; 10(1):21. PubMed ID: 28103947
[TBL] [Abstract][Full Text] [Related]
10. Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients.
Arruda LCM; Malmegrim KCR; Lima-Júnior JR; Clave E; Dias JBE; Moraes DA; Douay C; Fournier I; Moins-Teisserenc H; Alberdi AJ; Covas DT; Simões BP; Lansiaux P; Toubert A; Oliveira MC
Blood Adv; 2018 Jan; 2(2):126-141. PubMed ID: 29365321
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive assessment of T-cell repertoire following autologous hematopoietic stem cell transplantation for treatment of type 1 diabetes using high-throughput sequencing.
Zhang J; Hu M; Wang B; Gao J; Wang L; Li L; Chen S; Cui B; Gu W; Wang W; Ning G
Pediatr Diabetes; 2018 Nov; 19(7):1229-1237. PubMed ID: 30022578
[TBL] [Abstract][Full Text] [Related]
12. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
[TBL] [Abstract][Full Text] [Related]
13. Resetting the T Cell Compartment in Autoimmune Diseases With Autologous Hematopoietic Stem Cell Transplantation: An Update.
Lutter L; Spierings J; van Rhijn-Brouwer FCC; van Laar JM; van Wijk F
Front Immunol; 2018; 9():767. PubMed ID: 29731752
[TBL] [Abstract][Full Text] [Related]
14. Challenges and Opportunities for Biomarkers of Clinical Response to AHSCT in Autoimmunity.
Harris KM; Lu T; Lim N; Turka LA
Front Immunol; 2018; 9():100. PubMed ID: 29456529
[TBL] [Abstract][Full Text] [Related]
15. Autologous hematopoietic stem cell transplantation in systemic sclerosis induces long-lasting changes in B cell homeostasis toward an anti-inflammatory B cell cytokine pattern.
Gernert M; Tony HP; Schwaneck EC; Gadeholt O; Schmalzing M
Arthritis Res Ther; 2019 Apr; 21(1):106. PubMed ID: 31036055
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic and functional lymphocyte recovery after CD34+-enriched versus non-T cell-depleted autologous peripheral blood stem cell transplantation.
Nachbaur D; Kropshofer G; Heitger A; Lätzer K; Glassl H; Ludescher C; Nussbaumer W; Niederwieser D
J Hematother Stem Cell Res; 2000 Oct; 9(5):727-36. PubMed ID: 11091497
[TBL] [Abstract][Full Text] [Related]
17. Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple Sclerosis.
Massey J; Jackson K; Singh M; Hughes B; Withers B; Ford C; Khoo M; Hendrawan K; Zaunders J; Charmeteau-De Muylder B; Cheynier R; Luciani F; Ma D; Moore J; Sutton I
Front Immunol; 2022; 13():798300. PubMed ID: 35197974
[TBL] [Abstract][Full Text] [Related]
18. Resetting the immune response after autologous hematopoietic stem cell transplantation for autoimmune diseases.
Arruda LC; Clave E; Moins-Teisserenc H; Douay C; Farge D; Toubert A
Curr Res Transl Med; 2016; 64(2):107-13. PubMed ID: 27316394
[TBL] [Abstract][Full Text] [Related]
19. Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: From Mechanistic Insights to Biomarkers.
Malmegrim KCR; Lima-Júnior JR; Arruda LCM; de Azevedo JTC; de Oliveira GLV; Oliveira MC
Front Immunol; 2018; 9():2602. PubMed ID: 30505303
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphoma.
Laudi N; Arora M; Burns LJ; Miller JS; McGlave PB; Barker JN; Ramsay NK; Orchard PJ; Macmillan ML; Weisdorf DJ
Biol Blood Marrow Transplant; 2005 Feb; 11(2):129-35. PubMed ID: 15682074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
